327 filings
Page 2 of 17
8-K
tewg5mu
17 May 23
Submission of Matters to a Vote of Security Holders
4:03pm
PX14A6G
lisfajvmu7lrccs3
17 May 23
Letter to shareholders
4:00pm
PX14A6G
cc57ij41m uxe
11 May 23
Letter to shareholders
11:34am
DEFA14A
027vk9
8 May 23
Additional proxy soliciting materials
4:04pm
PX14A6G
gs5t64u0c8k
5 May 23
Letter to shareholders
11:17am
8-K
jqc vvd9n
4 May 23
Aurinia Pharmaceuticals Reports First Quarter 2023 Financial and Operational Results
6:06am
PX14A6G
aricj
3 May 23
Letter to shareholders
2:53pm
DEFA14A
0nv1cltblaev
2 May 23
Additional proxy soliciting materials
4:39pm
DEFA14A
15kus16fnk 7wxd7pgc
28 Apr 23
Additional proxy soliciting materials
4:03pm
PX14A6G
clraap406zyn
26 Apr 23
Letter to shareholders
10:20am
8-K
1eq hd334bbz
5 Apr 23
Aurinia Pharmaceuticals Announces Promising Topline Data from Renal Biopsy Sub-study of the AURORA Trial
8:16am
8-K
8fs8yo62
13 Mar 23
Other Events
6:03am
8-K
oauqb9257sv6fk
28 Feb 23
Aurinia Reports Fourth Quarter and Full Year 2022 Financial Results and Company Updates
6:03am
8-K
tva zug1nsrsybx4nj
27 Jan 23
Other Events
4:07pm
8-K
cqnmm1evqv
9 Jan 23
Aurinia Provides Preliminary Unaudited Fourth Quarter and Full-year 2022 Net Revenue Results
4:10pm
8-K
vmcjp u05q1j7e6wo
3 Jan 23
Other Events
4:34pm